Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$2.24 - $4.76 $6,224 - $13,228
-2,779 Reduced 3.47%
77,379 $174,000
Q4 2022

Feb 14, 2023

SELL
$2.17 - $35.84 $12,913 - $213,283
-5,951 Reduced 6.91%
80,158 $280,000
Q3 2022

Nov 14, 2022

SELL
$18.3 - $37.02 $12,297 - $24,877
-672 Reduced 0.77%
86,109 $3.19 Million
Q2 2022

Aug 15, 2022

BUY
$16.5 - $30.34 $260,403 - $478,825
15,782 Added 22.23%
86,781 $1.65 Million
Q1 2022

May 16, 2022

BUY
$16.72 - $26.99 $206,207 - $332,867
12,333 Added 21.02%
70,999 $1.62 Million
Q4 2021

Feb 14, 2022

SELL
$16.93 - $26.82 $34,689 - $54,954
-2,049 Reduced 3.37%
58,666 $1.32 Million
Q3 2021

Nov 12, 2021

BUY
$21.86 - $34.77 $53,054 - $84,386
2,427 Added 4.16%
60,715 $1.59 Million
Q2 2021

Aug 16, 2021

SELL
$29.55 - $39.15 $105,877 - $140,274
-3,583 Reduced 5.79%
58,288 $1.87 Million
Q1 2021

May 17, 2021

BUY
$31.52 - $39.28 $77,822 - $96,982
2,469 Added 4.16%
61,871 $2.18 Million
Q4 2020

Feb 16, 2021

BUY
$29.88 - $39.8 $168,463 - $224,392
5,638 Added 10.49%
59,402 $1.91 Million
Q3 2020

Nov 16, 2020

SELL
$34.42 - $43.78 $121,158 - $154,105
-3,520 Reduced 6.14%
53,764 $2.02 Million
Q2 2020

Aug 14, 2020

BUY
$31.59 - $49.98 $1.81 Million - $2.86 Million
57,284 New
57,284 $2.56 Million

Others Institutions Holding RLMD

About RELMADA THERAPEUTICS, INC.


  • Ticker RLMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,608,500
  • Market Cap $10.9M
  • Description
  • Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...
More about RLMD
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.